Page 46 - GPD-2-3
P. 46

Gene & Protein in Disease                                               Effect of phytochemicals in diabetes















































            Figure  2.  Docking  studies  of AMPK2  with  different  leads/ligands  at the molecular  level.  (A) Interaction  of AMPK2  with  metformin  (CID:  4091);
            (B) Interaction of AMPK2 with vindolinine (CID: 24148538); (C) Interaction of AMPK2 with vindoline (CID: 425978); (D) Interaction of AMPK2
            with (+)-vindorosine (CID: 261578); (E) Interaction of AMPK2 with Cr-1(CID-5315746); and (F) interaction of AMPK2 and Cr-2 (CID: 59908094). In
            subfigures, Image A shows about specific and reversible interaction of drug target AMPK2 and ligand/lead compound; Image B provides the insight of
            depth of the catalytic site of the target, similar to a real situation and distance between ligand and target around them, and target-ligand interaction within
            the active site of AMPK2 target based on H-bond donor and acceptor characteristic of amino acid residues; and Image C representing the 2D image,
            which is signifying the linkage between ligand and target amino acids residues. On the 2D map, the color lines indicated the following: Conventional
            H-bond interaction (green); carbon-hydrogen bond (sky blue); attractive charge interaction, π-anion interaction, and π-cation interaction (orange); alkyl
            interaction and π-alkyl interaction (pink); unfavorable acceptor-acceptor interaction and unfavorable positive-positive interaction (red).

            Table 9. The binding energy of docking interaction between   2.63 Å and 2.32 Å; two alkyl interaction with Arg263 and
            AMPK2 target and ligands (control and test compounds)  Lys260 of 4.13 Å and 4.21 Å, respectively; two attractive
                                                               charge interaction with residues Glu264 and Glu279 of
            Group   Docked compound     Binding energy (kcal/mol)  4.92 Å and 4.78 Å, respectively; and one intra molecular
            Control  AMPK2–metformin           −4.2            π-σ interaction of 3.73 Å. The potential binding affinity
            Test    AMPK2–vindoline            −6.2            energy between them is −5.3 kcal/mol (Table S2).
                    AMPK2–vindolinine          −5.6
                                                                 The binding affinity conformer (Figure  2F) of the
                    AMPK2–(+)-vindorosine      −5.6            AMPK2 and lead Cr-2 (CID: 59908094) docking pose
                    AMPK2–Cr1                  −5.3            shows that the lead attached to the active location of chain
                    AMPK2–Cr2                  −5.3            A of AMPK2, compartment residues Glu264, with one
                                                               intramolecular H-bond of 3.01 Å; conventional H-bond
            positively entering and attaching to the catalytic site of   connection with Lys260 of 2.30 Å; two carbon H-bond
            the AMPK2 chain A, through two conventional H-bond   links through Glu264 and Lys260 of 3.73 Å and 3.71 Å,
            interactions around catalytic pocket residues Arg263 of   respectively; single attractive charge interaction with



            Volume 2 Issue 3 (2023)                         8                        https://doi.org/10.36922/gpd.0927
   41   42   43   44   45   46   47   48   49   50   51